Onena Medicines secures 3.7 M Swiss francs investment

Onena Medicines closes 3.7M CHF funding round to advance its novel DSIP targeting antibody portfolio.Onena Medicines AG, a cellular reprogramming platform drug discovery company, announced…
andy03.11.2023